Skip to main content
Marla Keller, MD, Infectious Disease, Bronx, NY

MarlaJKellerMDFIDSA

Infectious Disease Bronx, NY

HIV/AIDS Medicine

Prof, Medicine, Infectious Diseases; OB/GYN and Women's Health, Albert Einstein College of Medicine

Dr. Keller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Keller's full profile

Already have an account?

  • Office

    1300 Morris Park Ave
    Mazer Building Room 512
    Bronx, NY 10461
    Phone+1 718-430-3240
    Fax+1 718-430-8879

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1996 - 1999
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1993 - 1996
  • New York University School of Medicine
    New York University School of MedicineClass of 1993

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1998 - 2025
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Montefiore and Einstein Hospitals Awarded Millions for COVID-19 Plasma Treatment
    Montefiore and Einstein Hospitals Awarded Millions for COVID-19 Plasma TreatmentAugust 19th, 2020
  • Montefiore, Einstein Publish COVID-19 Steroid Study
    Montefiore, Einstein Publish COVID-19 Steroid StudyJuly 31st, 2020
  • Einstein-Montefiore Study Results Align with RECOVERY Findings: Steroids Help Lower COVID-19 Death Rates & Blood Test Helps Select Patients
    Einstein-Montefiore Study Results Align with RECOVERY Findings: Steroids Help Lower COVID-19 Death Rates & Blood Test Helps Select PatientsJuly 27th, 2020
  • Join now to see all

Grant Support

  • Clinical Study To Measure Pharmacokinetics, Pharmacodynamics And Safety Of A TdfNational Institute Of Allergy And Infectious Diseases2011
  • Novel Mucosal Models Predictive Of Microbicide SafetyNational Institute Of Allergy And Infectious Diseases2010–2011
  • Safety Of Non-Medicated Intravaginal Rings For Microbicide DeliveryNational Institute Of Allergy And Infectious Diseases2010
  • Microbicide Effects On Efficacy, Safety, Innate ImmunityNational Institute Of Allergy And Infectious Diseases2007–2010
  • Novel Mucosal Models Predictive Of Microbicide SafetyNational Institute Of Allergy And Infectious Diseases2008–2009
  • Effects Of Hormones On Mucosal Immune Mediators Across The Menstrual CycleNational Center For Research Resources2007–2008
  • The Efficacy Of Samma And Its Leading Derivatives Against HIV-1National Center For Research Resources2007
  • Microbicide Effects On Efficacy, Safety, Innate ImmunityNational Institute Of Allergy And Infectious Diseases2005–2007
  • To Evaluate The Efficacy Of Samma And Its Leading Derivatives Against HIV-1National Center For Research Resources2006
  • Effect Of Repeated Applications Of PRO 2000/5 Gel (P) On Inflammatory MediatorsNational Center For Research Resources2006
  • Effects Of HIV On Bone Mass In The ElderlyNational Center For Research Resources2005–2006
  • Multitargeted Microbicide Combinations To Block HIVNational Center For Research Resources2004–2006
  • Effect Of Repeated Applications Of PRO 2000/5 Gel (P) On Inflammatory MediatoNational Center For Research Resources2005
  • To Evaluate The Efficacy Of Samma And Its Leading Derivatives Against HIV-1 U...National Center For Research Resources2004
  • In Vivo Antiviral &Inflammatory Effects Of MicrobicidesEunice Kennedy Shriver National Institute Of Child Health &Human Development2002

Professional Memberships